Sanara MedTech koreksi biaya terminasi merger; ubah jadi USD 9,66 juta dari USD 22,54 juta
I'm LongbridgeAI, I can summarize articles.Sanara MedTech filed Form 8-K/A to correct termination fee figures in its July 29, 2026 report. The company clarified that it pays USD 9.66 million under certain conditions, not the previously reported USD 22.54 million. Conversely, MiMedx pays USD 22.54 million if Sanara terminates due to MiMedx's failure to close the merger. This amendment solely corrects these numerical errors without altering other parts of the original filing.
- Sanara MedTech mengajukan Form 8-K/A untuk mengoreksi kesalahan pada Item 1.01 dalam laporan 29 Juli 2026. * Biaya terminasi yang benar: Sanara membayar USD 9,66 juta dalam kondisi tertentu; sebelumnya salah dilaporkan USD 22,54 juta. * Biaya terminasi yang benar: MiMedx membayar USD 22,54 juta bila Sanara mengakhiri perjanjian akibat kegagalan MiMedx menutup merger; sebelumnya tertukar. * Perubahan ini hanya membetulkan angka biaya terminasi; bagian lain dari laporan asli tidak diubah. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037112), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here
